9139B |
Clonazepam and Metabolite Screen, Blood |
9139FL |
Clonazepam and Metabolite Screen, Fluid |
9139SP |
Clonazepam and Metabolite Screen, Serum/Plasma |
9139U |
Clonazepam and Metabolite Screen, Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9171B |
Ethosuximide Screen, Blood |
9171SP |
Ethosuximide Screen, Serum/Plasma |
9171U |
Ethosuximide Screen, Urine |
9188B |
Ketamine and Metabolite Screen, Blood |
9188SP |
Ketamine and Metabolite Screen, Serum/Plasma |
9188U |
Ketamine and Metabolite Screen, Urine |
9205SP |
Dextro / Levo Methorphan Screen, Serum/Plasma |
9205U |
Dextro / Levo Methorphan Screen - Total, Urine |
9206U |
Dextrorphan / Levorphanol Screen - Total, Urine |
9215B |
Nitrazepam and Metabolite Screen, Blood |
9215SP |
Nitrazepam and Metabolite Screen, Serum/Plasma |
9233B |
Phensuximide Screen, Blood |
9233U |
Phensuximide Screen, Urine |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9401B |
Chloral Hydrate Screen, Blood |
9401SP |
Chloral Hydrate Screen, Serum/Plasma |
9401U |
Chloral Hydrate Screen, Urine |
9416B |
Phenobarbital Screen, Blood |
9443B |
Glutethimide Screen, Blood |
9443SP |
Glutethimide Screen, Serum/Plasma |